Use of sildenafil in a patient with pulmonary hypertension: A case report
Keywords:Hipertension, pulmonar; Sildenafil citrate; Lung diseases.
The aim of this study is to report a case of a patient with chronic obstructive pulmonary disease (COPD) and cystic fibrosis that evolved with pulmonary hypertension, reporting the clinical findings and the treatment instituted. Patients who have a chronic lung disease are more likely to develop pulmonary hypertension, a condition that leads to increased levels of pulmonary vascularization, a condition that leads to reduced carrier survival. The diagnosis of this condition can take up to 2 years, since most of the symptoms are nonspecific, in addition to the requirement for invasive methods to confirm the diagnosis. The patient in the clinical case showed signs suggestive of pulmonary hypertension, in addition to a chest X-ray consistent with the findings of this pathology, so treatment with a vasodilator was started. The vasodilator of choice was sildenafil because it is an agent that causes apparent benefits for the patient, without major repercussions on other body systems.
Barreto, S. S. M., & Gazzana, M. B. (2000). Hipertensão pulmonar: relato de seis casos e atualização do tema. Jornal de Pneumologia, 26(6), 321-336.
Calderaro, D., Alves Junior, J. L., Fernandes, C. J. C. dos S., & Souza, R. (2019). Hipertensão Pulmonar na Prática do Cardiologista. Arquivos Brasileiros de Cardiologia, 113(3), 419-428.
Freitas Jr., A. F. de, Bacal, F., Oliveira Jr., J. de L., Santos, R. H. B., Moreira, L. F. P., Silva, C. P., Mangini, S., Carneiro, R. M. D., Fiorelli, A. I., & Bocchi, E. A. (2009). Impacto do sildenafil sublingual na hipertensão pulmonar de pacientes com insuficiência cardíaca. Arquivos Brasileiros de Cardiologia, 92(2), 122-126.
Guimarães, A. C., Malachias, M. V. B., Coelho, O. R., Zilli, E. C., & Luna, R. L. (1999). Sildenafil em pacientes com doença cardiovascular. Arq Bras Cardiol. 73(6),
Hoette, S., Jardim, C., & Souza, R. (2010) Diagnosis and treatment of pulmonary hypertension: an update*. J Bras Pneumol. 36(6):795-811
Machado, R. F. P. (2008). Hipertensão pulmonar em pneumopatias crônicas: temos que aprender mais. Jornal Brasileiro de Pneumologia, 34(2), 65-66.
Oliveira, E. C., & Amaral, C. F. S. (2005). Sildenafil no tratamento da hipertensão arterial pulmonar idiopática em crianças e adolescentes. Jornal de Pediatria, 81(5), 390-394.
Ricachinevsky, C. P., & Amantéa, S. L. (2006). Manejo farmacológico da hipertensão arterial pulmonar. Jornal de Pediatria, 82(5), S153-S165.
Yoshida, W. B. (2007). Redação do relato de caso. J Vasc Bras. 6(2).
How to Cite
Copyright (c) 2021 Ilvanete Tavares Beltrão; Augusto César Beltrão da Silva; Renata Paula Lima Beltrão; Alba Angélica Nunes Mouta; Davi de Aguiar Portela; Camila Maila Fontinele Beltrão; Eduardo de Carvalho Carneiro; Bruna Caroline Ribeiro Beltrão; José Krentel Ferreira Neto
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.